Application of High-Fidelity Enzymes in In Vitro Diagnostic Reagent Development and Compliance Considerations

Applicable Scenarios of High-Fidelity Enzymes in In Vitro Diagnostics

In in vitro diagnostic reagents, high-fidelity enzymes can be used in scenarios requiring sequence accuracy or mutation identification, such as pathogen drug-resistance mutation detection, tumor-related genotyping, and genetic disease screening. Compared with ordinary amplification enzymes, high-fidelity enzymes can reduce non-target mutations during amplification and lower the risk of false positives or misjudgment caused by errors introduced by the enzyme. In multiplex PCR or high-throughput sequencing library construction, high-fidelity enzymes also help maintain template representativeness and reduce amplification bias. However, whether to use high-fidelity enzymes should be based on the product's intended use and methodological design. Not all assays have the same requirement for fidelity, and sensitivity, specificity, and cost considerations need to be comprehensively evaluated.

Raw Material Management and Supplier Evaluation

In the development of in vitro diagnostic reagents, high-fidelity enzymes are key raw materials, and their source, purity, and performance stability directly affect product quality. Enterprises should establish supplier evaluation and admission systems, focusing on the enzyme production process, residual impurities, animal-derived components, batch-to-batch consistency, and supply stability. When necessary, suppliers may be required to provide key performance indicators and change notifications. Incoming inspection can combine enzyme activity, fidelity verification, and functional testing to ensure that each batch of high-fidelity enzyme meets established standards. For products used in registration applications, raw material quality standards, test methods, and supplier information usually need to be clearly documented in the quality management system files for technical review or on-site audits.

Performance Verification and Process Stability

Performance verification of high-fidelity enzymes in IVD reagents generally includes analytical sensitivity, specificity, accuracy, and precision. Simulated clinical samples or reference materials should be used to evaluate amplification efficiency and mutation identification capability under different concentrations and different template backgrounds. In terms of process stability, attention should be paid to the performance of the enzyme under different freeze-thaw cycles, different batches of buffer, and different instrument platforms. If the reagent involves lyophilization or premixed liquid formats, the compatibility of the high-fidelity enzyme with protectants, primers, and probes should also be verified. A common practice is to design orthogonal experiments, optimize the ratios of magnesium ions, dNTPs, and enzyme amount, and fix key process parameters to reduce batch-to-batch variation.

Registration Compliance and Instructions for Use

In the registration application of in vitro diagnostic reagents, performance descriptions related to high-fidelity enzymes should be objective and evidence-based, avoiding absolute statements beyond the verified scope. The instructions for use and labels should clearly state the intended use, applicable sample types, limit of detection, limitations, and precautions. If the high-fidelity enzyme is used in sample pretreatment or library construction steps, its compatibility with downstream detection should be explained. Enterprises should retain complete design and development, verification, and change records to ensure traceability throughout the product life cycle. In addition, when pathogen detection is involved, biosafety, positive reference material management, and waste disposal requirements also need attention. Overall, the application of high-fidelity enzymes in the IVD field needs to be advanced simultaneously from both technical performance and regulatory compliance perspectives.